Department of Obstetrics & Gynecology, Ain Shams University, Cairo, Egypt

Publications

• Research   
  Different variables predicting ovulatory response among clomiphene citrate resistance and clomiphene citrate sensitive patients with polycystic ovarian syndrome
  Author(s): Ahmed Mohamed Rateb
  
  Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinological disorder seen in 6%–10% of women. It is a syndrome that manifests variably from adolescence as oligomenorrhea or hirsutism or obesity and goes on to affect the reproductive performance of the female by causing anovulation. Although lifestyle modification is known to improve reproductive outcomes in females with PCOS, the standard gold treatment for norm-gonadotropic oligo/amenorrheic infertility (WHO Group II) was clomiphene citrate (CC) (3) until 2018. Background: The purpose of the study was to evaluate the role of clinical, metabolic, hormonal, and ultrasound features of women with PCOS in predicting the response to clomiphene citrate. Patients & methods: This Prospective Observational study included 100 women with PCOs .. Read More»
  

  Abstract HTML PDF